Phillip G. Febbo

Insider Reports History

Entity
Individual
Location
C/O Genomic Health, Inc., 301 Penobscot Drive, Redwood City, CA
Signature
/s/ Jonathan Wygant, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phillip G. Febbo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERACYTE, INC. Chief Scientific & Med Officer Stock Option (right to buy) 85.9K $2.28M $26.55 Oct 2, 2023 Direct
VERACYTE, INC. Chief Scientific & Med Officer Common Stock 93.1K $2.23M $24.00 Mar 6, 2024 Direct
ILLUMINA, INC. SVP Chief Medical Officer Common Stock 14.8K $1.68M $113.48 Mar 1, 2023 Direct
ILLUMINA, INC. SVP Chief Medical Officer Performance Shares 4.53K Mar 1, 2023 Direct

Insider Reports Filed by Phillip G. Febbo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VCYT VERACYTE, INC. Mar 6, 2024 1 $0 4 Mar 8, 2024 Chief Scientific & Med Officer
VCYT VERACYTE, INC. Oct 2, 2023 2 $0 4 Oct 4, 2023 Chief Scientific & Med Officer
VCYT VERACYTE, INC. Oct 2, 2023 0 $0 3 Oct 4, 2023 Chief Scientific & Med Officer
ILMN ILLUMINA, INC. Mar 1, 2023 3 $0 4 Mar 3, 2023 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Feb 21, 2023 3 -$253K 4 Feb 23, 2023 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Nov 5, 2022 1 -$178K 4 Nov 8, 2022 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Apr 5, 2022 2 -$763K 4 Apr 7, 2022 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Mar 1, 2022 2 $0 4 Mar 3, 2022 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Feb 22, 2022 3 -$320K 4 Feb 24, 2022 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Nov 5, 2021 2 -$589K 4 Nov 9, 2021 SVP Chief Medical Officer
ILMN ILLUMINA, INC. Jun 11, 2021 3 -$448K 4 Jun 14, 2021 SVP Chief Medical Officer